The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

OpenAI is working on something big, developing its own brain-computer interface. But what does this actually mean?

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...